3 results
Study CA001-050 is a Phase 2 randomized, open label, multicenter clinical study designed to assess the safety and tolerability, of treatment with MS-986012 in combination with chemotherapy (carboplatin and etoposide) and nivolumab when administered…
To evaluate a new imaging based natural mapping strategy for CI fitting to optimize patient-related outcomes. Compared to conventional clinical fitting, it is proposed that this new method will improve speech understanding and sound perception in…
The first objective is to investigate whether biofeedback on HRV and voice volume will lead to a larger decrease of IPV compared to treatment as usual (CBT only). Second, to test the premise that IPV perpetrators have trouble self-observing bodily…